n.abubakar
Submits third-party assay reports on material purchased directly. Based in Turku.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
5
n=5
Annotations
0
n=0
Median purity submitted
99.23%
n=5
Suppliers covered
5
n=5
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042771 | Semax | GGPeps | GGPE-2512-Y1048 | Janoshik | 2026-Q2 | 99.69 | 7.30 | — | Supplier-supplied | 1 | FAIL |
| AX-2025-019042 | Liraglutide | ASY | ASY-{CAT}-2101 | Nordanalyt | 2025-Q4 | 99.86 | 3.41 | 92.7 | Buyer-sourced | 0 | PASS |
| AX-2025-020933 | Semaglutide | WXT | WXT-2505-E2684 | PeptideMeter | 2025-Q4 | 97.48 | 3.01 | — | Buyer-sourced | 0 | PASS |
| AX-2025-019194 | BPC-157 | SinoPep | SNP-2506-U4547 | PeptideMeter | 2025-Q3 | 98.19 | 5.66 | 96.8 | Buyer-sourced | 1 | MARGINAL |
| AX-2024-004364 | Tirzepatide | FGP | FGP-2408-H8588 | Janoshik | 2024-Q4 | 99.23 | 7.37 | 99.8 | Buyer-sourced | 1 | MARGINAL |